Bellerophon Therapeutics Correlations
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
The current 90-days correlation between Bellerophon Therapeutics and Altamira Therapeutics is 0.16 (i.e., Average diversification). The correlation of Bellerophon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bellerophon Therapeutics Correlation With Market
Good diversification
The correlation between Bellerophon Therapeutics and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bellerophon Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Bellerophon |
The ability to find closely correlated positions to Bellerophon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellerophon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellerophon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellerophon Therapeutics to buy it.
Moving together with Bellerophon Pink Sheet
| 0.68 | VALN | Valneva SE ADR | PairCorr |
| 0.67 | DRMA | Dermata Therapeutics | PairCorr |
| 0.77 | DTIL | Precision BioSciences | PairCorr |
| 0.93 | VINC | Vincerx Pharma | PairCorr |
| 0.7 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.77 | CDTTW | Conduit Pharmaceuticals | PairCorr |
Moving against Bellerophon Pink Sheet
| 0.9 | DRUG | Bright Minds Biosciences Trending | PairCorr |
| 0.68 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.6 | VCYT | Veracyte | PairCorr |
| 0.55 | VERA | Vera Therapeutics | PairCorr |
| 0.54 | VAXX | Vaxxinity | PairCorr |
| 0.48 | DSGN | Design Therapeutics | PairCorr |
| 0.45 | VANI | Vivani Medical | PairCorr |
| 0.36 | DMAC | DiaMedica Therapeutics Trending | PairCorr |
| 0.88 | VRNA | Verona Pharma PLC | PairCorr |
| 0.82 | VSTM | Verastem Trending | PairCorr |
| 0.47 | KTTAW | Pasithea Therapeutics | PairCorr |
| 0.46 | VRDN | Viridian Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bellerophon Pink Sheet performing well and Bellerophon Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bellerophon Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BPTH | 4.02 | (0.38) | 0.00 | 8.80 | 0.00 | 6.67 | 51.22 | |||
| CBIO | 4.25 | 0.92 | 0.12 | 2.30 | 4.45 | 9.76 | 38.47 | |||
| DFFN | 2.40 | (0.42) | 0.00 | 0.63 | 0.00 | 4.09 | 12.34 | |||
| CAPR | 6.70 | 2.60 | 0.49 | 15.47 | 4.05 | 18.22 | 69.31 | |||
| NXTC | 2.58 | (0.37) | 0.00 | 1.76 | 0.00 | 5.22 | 21.68 | |||
| ZURA | 3.79 | (0.66) | 0.00 | (0.19) | 0.00 | 7.95 | 26.70 | |||
| CYTO | 3.53 | (1.15) | 0.00 | (8.98) | 0.00 | 6.98 | 22.81 | |||
| IMMX | 4.25 | (0.12) | (0.02) | 0.01 | 4.55 | 9.38 | 32.68 | |||
| ENVB | 3.25 | (0.61) | 0.00 | (3.83) | 0.00 | 6.25 | 28.33 |
Bellerophon Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bellerophon Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Bellerophon Therapeutics could also be used in its relative valuation, which is a method of valuing Bellerophon Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Still Interested in Bellerophon Therapeutics?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.